The introduction of PSMA PET/CT at Medya Diagnostic Center marks a significant advancement in prostate cancer diagnostics in Iraq, enhancing detection accuracy and staging capabilities, particularly for metastatic disease. Here, FOLH1 is linked to prostate carcinoma.